An mRNA-lipid nanoparticle vaccine targeting the Plasmodium vivax E140 antigen
Molecular Therapy: Nucleic Acids
· Elsevier
Аннотация
Publication date: 8 December 2026 Source: Molecular Therapy Nucleic Acids, Volume 37, Issue 4 Author(s): Rodolfo Ferreira Marques, Guilherme Antonio de Souza-Silva, Vitor Antunes da Silva, András Sárközy, Máté Vadovics, Hiromi Muramatsu, Edit Ábrahám, Carolina Bioni Garcia, Silvia Beatriz Boscardin, Rachel H.J. Jun, Anna Caroline Campos Aguiar, Zoltan Lipinszki, Norbert Pardi, Daniel Youssef Bargieri
Читать у издателя →
Цитировать
Получайте новые статьи по теме «Поиск и разработка лекарств»
Подписка, поиск по ключевым словам и избранное — в Telegram-боте Articlium.
Открыть в Telegram
Цитирование
✕
ГОСТ
APA
MLA
BibTeX
An mRNA-lipid nanoparticle vaccine targeting the Plasmodium vivax E140 antigen. // Molecular Therapy: Nucleic Acids. – URL: https://www.sciencedirect.com/science/article/pii/S2162253126002544?dgcid=rss_sd_all
An mRNA-lipid nanoparticle vaccine targeting the Plasmodium vivax E140 antigen. Molecular Therapy: Nucleic Acids. https://www.sciencedirect.com/science/article/pii/S2162253126002544?dgcid=rss_sd_all
“An mRNA-lipid nanoparticle vaccine targeting the Plasmodium vivax E140 antigen.” Molecular Therapy: Nucleic Acids.
@article{article59487,
title = {An mRNA-lipid nanoparticle vaccine targeting the Plasmodium vivax E140 antigen},
journal = {Molecular Therapy: Nucleic Acids},
url = {https://www.sciencedirect.com/science/article/pii/S2162253126002544?dgcid=rss_sd_all}
}